23.4 C
New York
Tuesday, May 21, 2024

CTG Announces Extension of 10b5-1 Plan to Facilitate Share Repurchases

Courtesy of Benzinga.

China Cord Blood Corporation (NYSE: CO) today announced that the Company repurchased an aggregate of 2,191,412 ordinary shares for a total consideration of approximately $6.2 million since August 2011. The total number of shares repurchased represents approximately 41% of the total $15 million authorized under the existing buyback program, which was authorized by the Board in August 2011, leaving approximately $8.8 million still available for repurchase.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,188FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x